These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4998363)

  • 1. [A new oral antidiabetic: glibenclamide].
    Pérez Vitoria C
    Rev Iber Endocrinol; 1969; 16(95):367-71. PubMed ID: 4998363
    [No Abstract]   [Full Text] [Related]  

  • 2. [Modern oral sugar-reducing drugs: focus to glibenclamide].
    Ushakova EA
    Ter Arkh; 2007; 79(12):86-90. PubMed ID: 18220041
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study of glibenclamide, a new oral hypoglycemic agent].
    Iunes M; Mazzarollo DN; Reis LC
    AMB Rev Assoc Med Bras; 1971 May; 17(5):169-74. PubMed ID: 4997760
    [No Abstract]   [Full Text] [Related]  

  • 4. [Testing a new antidiabetic (Glibenclamid) in hospitalized and ambulatory diabetics].
    Belser F; Brögli H; Constam G; Zollikofer H
    Schweiz Rundsch Med Prax; 1970 Apr; 59(16):598-601. PubMed ID: 4997187
    [No Abstract]   [Full Text] [Related]  

  • 5. [What is new in the treatment of diabetes mellitus?].
    Gain T
    Krankenpfl J; 2000 Oct; 38(9-10):328-31. PubMed ID: 11194350
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical pharmacology of oral antidiabetic agents (second of two parts).
    Shen SW; Bressler R
    N Engl J Med; 1977 Apr; 296(14):787-93. PubMed ID: 320484
    [No Abstract]   [Full Text] [Related]  

  • 7. The development of an oral antidiabetic combination tablet: design, evaluation and clinical benefits for patients with type 2 diabetes.
    Howlett H; Porte F; Allavoine T; Kuhn T; Nicholson G
    Curr Med Res Opin; 2003; 19(3):218-25. PubMed ID: 12803736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oral hypoglycemic agents].
    Mirouze J
    Rev Clin Esp; 1978 Mar; 148(6):575-8. PubMed ID: 663333
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetes caused by Kir6.2 mutation: successful treatment with oral glibenclamide switched from continuous subcutaneous insulin infusion in the early phase of the disease.
    Nagano N; Urakami T; Mine Y; Watanabe H; Yoshida A; Suzuki J; Saito H; Ishige M; Takahashi S; Mugishima H; Yorifuji T
    Pediatr Int; 2012 Apr; 54(2):277-9. PubMed ID: 22507152
    [No Abstract]   [Full Text] [Related]  

  • 10. [Our experiences with butyl-biguanide, a new Hungarian oral antidiabetic].
    Halmos T; Loczka B; Salamon F
    Orv Hetil; 1966 Oct; 107(41):1938-9. PubMed ID: 5978536
    [No Abstract]   [Full Text] [Related]  

  • 11. Tolinase--a new oral antidiabetic drug.
    Med Lett Drugs Ther; 1966 Sep; 8(19):77-8. PubMed ID: 5971398
    [No Abstract]   [Full Text] [Related]  

  • 12. [Peroral therapy of diabetes mellitus].
    Vasiukova EA; Granovskaia-Tsvetkova AM
    Sov Med; 1975 Oct; (10):25-9. PubMed ID: 813303
    [No Abstract]   [Full Text] [Related]  

  • 13. The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes).
    Kardas P
    Diabetes Obes Metab; 2005 Nov; 7(6):722-8. PubMed ID: 16219016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are you up to date on diabetes medications?
    Kestel F
    Am J Nurs; 1994 Jul; 94(7):48-52. PubMed ID: 8017497
    [No Abstract]   [Full Text] [Related]  

  • 15. [Oral anti-diabetic agents: update].
    Ruiz J
    Rev Med Suisse Romande; 2001 Sep; 121(9):655-61. PubMed ID: 11723707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with the oral administration of the antidiabetic buformin.
    Sieberová R
    Rev Czech Med; 1971; 17(4):219-21. PubMed ID: 5122079
    [No Abstract]   [Full Text] [Related]  

  • 17. The oral antidiabetic drugs: pro and con.
    Fletcher HP
    Am J Nurs; 1976 Apr; 76(4):596-9. PubMed ID: 1046887
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative clinical study of the oral hypoglycemic agent HB 419 or glibenclamide].
    Giraudo JR
    Rev Clin Esp; 1972 Nov; 127(3):815-20. PubMed ID: 4631447
    [No Abstract]   [Full Text] [Related]  

  • 19. [A new oral antidiabetic agent in internal medicine practice].
    Stockmann B; Cannstatt SB
    Med Welt; 1974 Jul; 25(29):1248-50. PubMed ID: 4847958
    [No Abstract]   [Full Text] [Related]  

  • 20. [Controlled clinical study of a new oral antidiabetic formed by a glibenclamide-phenformin association].
    Torri A; Zanni A
    Clin Ter; 1974 Aug; 70(3):236-57. PubMed ID: 4214456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.